Hans Lilja

40.1k total citations · 8 hit papers
453 papers, 25.3k citations indexed

About

Hans Lilja is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Hans Lilja has authored 453 papers receiving a total of 25.3k indexed citations (citations by other indexed papers that have themselves been cited), including 312 papers in Pulmonary and Respiratory Medicine, 98 papers in Molecular Biology and 54 papers in Surgery. Recurrent topics in Hans Lilja's work include Prostate Cancer Treatment and Research (285 papers), Prostate Cancer Diagnosis and Treatment (230 papers) and Urologic and reproductive health conditions (52 papers). Hans Lilja is often cited by papers focused on Prostate Cancer Treatment and Research (285 papers), Prostate Cancer Diagnosis and Treatment (230 papers) and Urologic and reproductive health conditions (52 papers). Hans Lilja collaborates with scholars based in Sweden, United States and Finland. Hans Lilja's co-authors include Andrew J. Vickers, Åke Lundwall, Anders Christensson, Kim Pettersson, David Ulmert, Anders Bjartell, Peter T. Scardino, Jonas Hugosson, Per‐Anders Abrahamsson and Anders Selbing and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hans Lilja

448 papers receiving 24.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intrauterine growth curves based on ultrasonically estimated foetal weights

1996 1.6k citations Hans Lilja et al. profile →
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin

1991 778 citations Hans Lilja, Kim Pettersson et al. profile →
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring

2008 691 citations Hans Lilja, David Ulmert et al. profile →
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

2010 614 citations Sigrid Carlsson, Hans Lilja et al. profile →
A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

1985 592 citations Hans Lilja profile →
Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitors

1990 560 citations Hans Lilja et al. profile →
Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer

1993 534 citations Thomas Björk, Hans Lilja et al. profile →
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

2007 522 citations Hans Lilja, Steven M. Larson et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Hans Lilja

Since Specialization

Citations

This map shows the geographic impact of Hans Lilja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Lilja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Lilja more than expected).

Fields of papers citing papers by Hans Lilja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Lilja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Lilja. The network helps show where Hans Lilja may publish in the future.

Co-authorship network of co-authors of Hans Lilja

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Lilja. A scholar is included among the top collaborators of Hans Lilja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Lilja. Hans Lilja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing 2025 ·JAMA Oncology ·(unknown), (unknown), Emily Vertosick, Sunny Nalavenkata, (unknown), Andrew J. Vickers, Hans Lilja, James A. Eastham, Sigrid Carlsson	0
2	Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response 2023 ·Molecular Cancer Research ·(unknown), (unknown), Mesude Bicak, Darren R. Veach, Katharina Lückerath, Gabriel Adrian, Michael R. McDevitt, Teja Kalidindi, Julie E. Park, Ken Herrmann, Diane S. Abou, (unknown), Norbert Peekhaus, Robert J. Klein, Robert Damoiseaux, Steven M. Larson, Hans Lilja, Daniel L.J. Thorek, David Ulmert	2
3	Association of Prostate-Specific Antigen Levels with Prostate Cancer Risk in a Multiethnic Population: Stability Over Time and Comparison with Polygenic Risk Score 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Alisha Chou, Burcu F. Darst, Lynne R. Wilkens, Loı̈c Le Marchand, Hans Lilja, David V. Conti, Christopher A. Haiman	5
4	Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study 2021 ·British Journal of Urology ·Antti Rannikko, (unknown), Tuomas Mirtti, (unknown), Teemu Tolonen, Irina Rinta‐Kiikka, Tuomas P. Kilpeläinen, Kari Natunen, Hans Lilja, Terho Lehtimäki, Jani Raitanen, Paula Kujala, (unknown), Mika Matikainen, Anssi Pétas, Kimmo Taari, Teuvo L.J. Tammela, Anssi Auvinen	12
5	Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts 2018 ·Clinical Cancer Research ·Kwanghee Kim, Philip A. Watson, Souhil Lebdai, (unknown), (unknown), (unknown), (unknown), Katie S. Murray, Hans Lilja, David Ulmert, Sébastien Monette, Avigdor Scherz, Jonathan Coleman	17
6	Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer 2018 ·Clinical Cancer Research ·Daniel L.J. Thorek, Anson T. Ku, Nicholas Mitsiades, Darren R. Veach, Philip A. Watson, (unknown), Sven‐Erik Strand, Sai Kiran Sharma, Jason S. Lewis, Diane S. Abou, Hans Lilja, Steven M. Larson, Michael R. McDevitt, David Ulmert	21
7	Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer 2018 ·Nature Communications ·Michael R. McDevitt, Daniel L.J. Thorek, Takeshi Hashimoto, Tatsuo Gondo, Darren R. Veach, Sai Kiran Sharma, Teja Kalidindi, Diane S. Abou, Philip A. Watson, Bradley J. Beattie, (unknown), Sven‐Erik Strand, Jason S. Lewis, Peter T. Scardino, Howard I. Scher, Hans Lilja, Steven M. Larson, David Ulmert	39
8	Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort 2013 ·European Journal of Cancer ·Signe Benzon Larsen, Klaus Brasso, Peter Iversen, Jane Christensen, Michael Christiansen, Sigrid Carlsson, Hans Lilja, Søren Friis, Anne Tjønneland, Susanne Oksbjerg Dalton	8
9	Improved porous silicon microarray based prostate specific antigen immunoassay by optimized surface density of the capture antibody 2013 ·Analytica Chimica Acta ·(unknown), Soyoun Kim, Johan Malm, Ok Chan Jeong, Hans Lilja, Thomas Laurell	20
10	Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens 2013 ·Clinical Biochemistry ·(unknown), Hans Lilja, Angel M. Cronin, (unknown), (unknown), Otto Kauko, (unknown), (unknown), Martti Nurmi, Kalle Alanen, Kim Pettersson	10
11	Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen 2012 ·Cancer Discovery ·David Ulmert, Michael J. Evans, Jason P. Holland, Samuel L. Rice, John Wongvipat, Kim Pettersson, Per-Anders Abrahamsson, Peter T. Scardino, Steven M. Larson, Hans Lilja, Jason S. Lewis, Charles L. Sawyers	58
12	Measuring density and compressibility of white blood cells and prostate cancer cells by microchannel acoustophoresis 2011 ·Lund University Publications (Lund University) ·Rune Barnkob, Per Augustsson, Cecilia Magnusson, Hans Lilja, Thomas Laurell, Henrik Bruus	9
13	Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer 2010 ·Cancer Prevention Research ·Robert J. Klein, Christer Halldén, Angel M. Cronin, Alexander Ploner, Fredrik Wiklund, Anders Bjartell, Pär Stattin, Jianfeng Xu, Peter T. Scardino, Kenneth Offit, Andrew J. Vickers, Henrik Grönberg, Hans Lilja	45
14	Polymorphisms at the Microseminoprotein-β Locus Associated with Physiologic Variation in β-Microseminoprotein and Prostate-Specific Antigen Levels 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Xing Xu, Camilla Valtonen‐André, (unknown), Christer Halldén, Hans Lilja, Robert J. Klein	21
15	A Common Prostate Cancer Risk Variant 5′ of Microseminoprotein-β (MSMB) Is a Strong Predictor of Circulating β-Microseminoprotein (MSP) Levels in Multiple Populations 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Kevin Waters, Daniel O. Stram, Loı̈c Le Marchand, Robert J. Klein, Camilla Valtonen‐André, Mari Peltola, Laurence N. Kolonel, Brian E. Henderson, Hans Lilja, Christopher A. Haiman	14
16	A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam 2010 ·Clinical Cancer Research ·Andrew J. Vickers, Angel M. Cronin, Monique J. Roobol, Caroline Savage, Mari Peltola, Kim Pettersson, Peter T. Scardino, Fritz H. Schröder, Hans Lilja	95
17	Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication 2010 ·Journal of Clinical Oncology ·Andrew J. Vickers, Angel M. Cronin, Monique J. Roobol, Caroline Savage, Mari Peltola, Kim Pettersson, Peter T. Scardino, Fritz H. Schröder, Hans Lilja	167
18	Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer 2008 ·Journal of Clinical Oncology ·Andrew J. Vickers, Caroline Savage, M. Frank O’Brien, Hans Lilja	185
19	A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue 2007 ·Biological Chemistry ·Camilla Valtonen‐André, Anders Bjartell, Rebecka Hellsten, Hans Lilja, Pirkko Härkönen, Åke Lundwall	18
20	The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically‐based screening strategy 2007 ·International Journal of Cancer ·Andrew J. Vickers, David Ulmert, Angel M. Serio, Thomas Björk, Peter T. Scardino, James A. Eastham, Göran Berglund, Hans Lilja	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact